Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…

Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Postpartum, post-abortion and perimenopausal contraception

Obstetrics and gynaecology · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Fertility returns before expected bleeding

Ovulation can precede the first period after birth, abortion or pregnancy loss; unprotected intercourse from day 21 postpartum or from day 5 after pregnancy ends may require emergency contraception.

Action: Establish the pregnancy-end and intercourse dates immediately, offer a copper IUD or appropriate oral emergency contraception within its window, then quick-start or insert ongoing contraception with correct backup.

Synopsis

Provide contraception across rapid fertility transitions after birth, abortion or pregnancy loss and through perimenopause, using correct start windows, thrombosis assessment and stopping rules.

  • Discuss postpartum contraception antenatally and provide the chosen method before discharge where possible; fertility intention and consent must be revisited after birth rather than assumed.
  • The implant and POP can start immediately after childbirth. DMPA can also be provided postpartum when medically eligible, with bleeding, bone and fertility-return counselling.
  • Insert a copper or levonorgestrel IUD within 48 hours of birth, including at caesarean, or wait until at least four weeks postpartum if that immediate window is missed.
  • Before three weeks postpartum, CHC is UKMEC 4 with additional VTE factors and 3 without them; breastfeeding makes CHC category 4 until six weeks. From three to six weeks, apply the current category rather than a calendar rule alone.
  • All contraceptive methods can generally be started immediately after abortion or pregnancy loss when clinically appropriate; immediate provision prevents loss to follow-up and does not impair future fertility.
  • Emergency contraception is considered from day 21 after birth unless strict lactational-amenorrhoea criteria apply, and from day 5 after abortion, miscarriage, ectopic treatment or uterine evacuation.
  • In perimenopause, HRT is not contraception. Eligible nonsmokers may use CHC until age 50; POP, implant and suitable intrauterine methods can continue longer under method-specific rules.
  • Without hormonal contraception, stop after two years of amenorrhoea if under 50, one year if 50 or older, or at age 55 when spontaneous conception is exceptionally rare.

Key red flags

Heavy bleeding, fever, offensive discharge, severe pelvic pain or systemic illness after birth or abortion may indicate haemorrhage, retained tissue, endometritis or sepsis and needs urgent assessment before routine contraceptive care.

Unilateral leg swelling, chest pain or sudden breathlessness postpartum may represent venous thromboembolism; do not start oestrogen and arrange emergency assessment.

A positive pregnancy test with pain or bleeding after abortion or miscarriage may represent persisting pregnancy, retained tissue, ectopic pregnancy or a new conception and requires prompt location assessment.

New postcoital, persistent intermenstrual or postmenopausal bleeding in perimenopause requires diagnostic assessment rather than being labelled a normal hormonal transition.

Investigation priorities

01
Pregnancy and intercourse chronologyFirst step

Determine immediate initiation, emergency contraception and repeat-testing requirements after pregnancy.

Management branches

Postpartum first lineProvide before fertility returns

Contraception is requested antenatally or after childbirth.

  1. Reconfirm reproductive intention and medical eligibility after birth, including breastfeeding, VTE factors, bleeding and whether the patient still wants the antenatal choice.
  2. Offer immediate POP, implant or eligible DMPA, or intrauterine placement within 48 hours; if that IUD window is missed, arrange insertion from four weeks.
  3. Delay CHC for at least 21 days and longer when breastfeeding or thrombosis factors require it, using an effective bridge and exact start precautions.
Post-abortion first lineStart at completion

An abortion, miscarriage or ectopic pregnancy has been managed and contraception is wanted.

  1. Offer all suitable methods before discharge and verify completion when intrauterine insertion follows a medical process.
  2. Start pills, implant or injection immediately and insert an IUD at surgical treatment or after completion according to the service pathway.
  3. If initiation occurs more than five days after pregnancy ends, apply method-specific backup and assess intercourse from day 5 for emergency contraception.

Key medicines

Desogestrel 75 microgram progestogen-only pill postpartumTake one tablet orally at the same time every day without a hormone-free interval; it may be started immediately after childbirth with start and missed-pill precautions given for the exact timing.Check breast and liver eligibility, enzyme-inducing medicines, irregular bleeding and product-specific missed-pill rules; it does not protect against STIs.
Levonorgestrel 52 mg intrauterine device for contraception and HRTInsert one 52 mg device at a valid postpartum or interval time; document separate replacement dates when it provides contraception and when it supplies endometrial protection with systemic oestrogen HRT.Immediate postpartum insertion has higher expulsion risk; assess pregnancy, infection, cavity and breast eligibility and never extend the HRT-protection interval from the longer contraceptive duration.
Open full textbook →Answer 2 questions
Sources and review status4 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • CoSRH contraception after pregnancy guidelinePostpartum and post-pregnancy initiation and emergency timing.
  • CoSRH contraception over 40 guidelinePerimenopausal eligibility, extended use and stopping rules.
  • CoSRH contraception FAQsCurrent patient-facing age, HRT and contraception advice.
  • CoSRH UKMEC 2025Postpartum and age-related medical eligibility.

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom